Close
Subscribe to newsletters
Email:

Welcome to Winning The Fight

View studies in world renowned scientific journals confirming the effectiveness of the Deanna ProtocolTM therapy for ALS!

What is Winning the Fight

Winning the Fight against Neurodegenerative Diseases, otherwise known as Winning the Fight (WFND), is a mostly volunteer 501(c)3 non-profit organization. We focus on designing and studying nutritional therapies for Amyotrophic Lateral Sclerosis, otherwise known as Lou Gherig’s Disease. We developed a therapy for ALS called the Deanna Protocol TM  and scientific studies show that the therapy is indeed effective! We do not directly sell the nutritional supplements involved in the Deanna Protocol and we make very little money when individuals purchase them. The money we do make is donated directly toward research to improve the Deanna ProtocolTM  nutritional therapy. In addition to improving the Deanna ProtocolTM for ALS, we also hope to eventually optimize it to target other neurodegenerative diseases (NDs) such as Alzhiemer's Disease, Parkinson's Disease, and Multiple Sclerosis. If you would like to support our research, please donate today! Even one cent will help!

 

Organizational Structure: Volunteers and Paid Personnel

Our organization consist of a board of nine directors, a medical liaison, and several experts in the fields of neurology, all of whom are volunteers. The only individuals paid for their work for WFND are the scientists who conduct our research, one part time administrative assistant, and one part time freelance web developer who helps us resolve technical issues as-needed. If you donate to our organization, you can rest assured that the vast majority of your money will fund research to improve the Deanna Protocol TM! This research will help us lengthen and improve the lives of those with ALS!

 

RSS

News

Examiner Article - Thursday, July 31, 2014
The Examiner published an article on the Deanna Protocol and explained the studies that prove its effectiveness.
details
ALS Untangled wrote an article evaluating the Deanna Protocol - Sunday, August 4, 2013
ALS Untangled wrote an article evaluating the Deanna Protocol and addressed several concerns. WFND has responded and answered ALS Untangled's concerns in a separate article. Please see ALS Untangled's article and WFND's responding article.
details
FDA Hearing Highlights ALS Drug Development Concerns - Wednesday, February 27, 2013
•At a public hearing Monday, Feb. 25, 2013, conducted by the U.S. Food and Drug Administration, people with ALS and their families, clinicians and other medical professionals urged the FDA to consider the unique needs of patients and their families — for whom time is of the essence — when considering trial design and review of therapies for ALS. •Input in the form of verbal and written remarks was given by patients, caregivers, advocates, health care providers, academia, industry and others — including MDA President and CEO Steven M. Derks and Stan Appel, who directs the MDA/ALS Center at Methodist Neurological Institute in Houston. •The public may continue to submit comments to the FDA on this subject through March 25, 2013.
details